Uncategorized

News And Events Babraham-based ImmBio signs deal with CNBG in China to develop pneumococcal disease vaccine It kills about 1.5 million people every year – more than TB, HIV and malaria combined. A pneumococcal vaccine is given to children and over-65s in the UK (7863563)And current vaccines target only a handful of the approximately 97 …

Babraham-based ImmBio signs deal with CNBG in China to develop pneumococcal disease vaccine Read More »

News And Events Sareum Signs Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that it has entered into an agreement (the “Agreement”) with a China-based specialty pharmaceutical company (the “Licensee). Under …

Sareum Signs Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company Read More »

News And Events Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon in China (September 7, 2022, Rapperswil, Switzerland and Shanghai, China) Neovii Pharmaceuticals AG (“Neovii”), a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd (“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun …

Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon in China Read More »